Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Escitalopram in the Long-term Treatment of Major Depressive Disorder With Associated Anxiety Symptom

NCT01814098 is registered in ClinicalTrials.gov with Xian-Janssen Pharmaceutical Ltd. as lead sponsor.

NCT NCT01814098
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01814098 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Escitalopram in the Long-term Treatment of Major Depressive Disorder With Associated Anxiety Symptom
Lead sponsor
Xian-Janssen Pharmaceutical Ltd.
Phase
Phase 4
Overall status
Completed
Start date
July 7, 2009
Completion date
November 30, 2011
Enrollment
318 (actual)
Sites
10

Conditions

As the registry lists them; a condition with its own page is linked.

depressive disorder, major